Recent advancements of flow cytometry: new applications in hematology and oncology

Should evaluation for minimal residual disease be routine in acute myeloid leukemia?

(2013) Elaine Coustan-Smith et al.   CURRENT OPINION IN HEMATOLOGY

Photoacoustic and photothermal detection of circulating tumor cells, bacteria and nanoparticles in cerebrospinal fluidin vivoandex vivo

(2013) Dmitry A. Nedosekin et al.   Journal of Biophotonics

Minimal Residual Disease Assessed by Multiparameter Flow Cytometry in Multiple Myeloma: Impact on Outcome in the Medical Research Council Myeloma IX Study

(2013) Andy C. Rawstron et al.   JOURNAL OF CLINICAL ONCOLOGY

DOT1L-Mediated H3K79 Methylation in Chromatin Is Dispensable for Wnt Pathway-Specific and Other Intestinal Epithelial Functions

(2013) Li-Lun Ho et al.   MOLECULAR AND CELLULAR BIOLOGY

Quantification of minimal residual disease levels by flow cytometry at time of transplant predicts outcome after myeloablative allogeneic transplantation in ALL

(2012) J Sanchez-Garcia et al.   BONE MARROW TRANSPLANTATION

Minimal Residual Disease Quantification Is an Independent Predictor of Progression-Free and Overall Survival in Chronic Lymphocytic Leukemia: A Multivariate Analysis From the Randomized GCLLSG CLL8 Trial

(2012) Sebastian Böttcher et al.   JOURNAL OF CLINICAL ONCOLOGY

Alemtuzumab in Combination With Methylprednisolone Is a Highly Effective Induction Regimen for Patients With Chronic Lymphocytic Leukemia and Deletion of TP53: Final Results of the National Cancer Research Institute CLL206 Trial

(2012) Andrew R. Pettitt et al.   JOURNAL OF CLINICAL ONCOLOGY

EuroFlow standardization of flow cytometer instrument settings and immunophenotyping protocols

(2012) T Kalina et al.   LEUKEMIA

Photoacoustic flow cytometry

(2012) Ekaterina I. Galanzha et al.   METHODS

In Vivo Magnetic Enrichment, Photoacoustic Diagnosis, and Photothermal Purging of Infected Blood Using Multifunctional Gold and Magnetic Nanoparticles

(2012) Ekaterina I. Galanzha et al.   PLoS One

A deep profiler's guide to cytometry

(2012) Sean C. Bendall et al.   TRENDS IN IMMUNOLOGY

Cutaneous T-cell lymphoma: 2011 update on diagnosis, risk-stratification, and management

(2011) Ryan A. Wilcox   AMERICAN JOURNAL OF HEMATOLOGY

Prognostic and therapeutic implications of minimal residual disease detection in acute myeloid leukemia

(2011) F. Buccisano et al.   BLOOD

In vivo ultra-fast photoacoustic flow cytometry of circulating human melanoma cells using near-infrared high-pulse rate lasers

(2011) Dmitry A. Nedosekin et al.   CYTOMETRY PART A

Multiphoton flow cytometry strategies and applications

(2011) Eric R. Tkaczyk et al.   CYTOMETRY PART A

In vivo flow cytometry of circulating clots using negative photothermal and photoacoustic contrasts

(2011) Ekaterina I. Galanzha et al.   CYTOMETRY PART A

In vivo flow cytometry: A horizon of opportunities

(2011) Valery V. Tuchin et al.   CYTOMETRY PART A

Impact of Pretransplantation Minimal Residual Disease, As Detected by Multiparametric Flow Cytometry, on Outcome of Myeloablative Hematopoietic Cell Transplantation for Acute Myeloid Leukemia

(2011) Roland B. Walter et al.   JOURNAL OF CLINICAL ONCOLOGY

Searching for surrogates for IGHV mutations in chronic lymphocytic leukemia

(2011) Terry J. Hamblin   LEUKEMIA RESEARCH

Minimal Residual Disease in Acute Lymphoblastic Leukemia

(2011) D. Campana   Hematology-American Society of Hematology Education Program

Synthesis of a Functional Metal-Chelating Polymer and Steps toward Quantitative Mass Cytometry Bioassays

(2010) Daniel Majonis et al.   ANALYTICAL CHEMISTRY

The role of multiparameter flow cytometry for disease monitoring in AML

(2010) Wolfgang Kern et al.   BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY

Assessment of minimal residual disease in acute myeloid leukemia

(2010) David Grimwade et al.   CURRENT OPINION IN ONCOLOGY

Relationship between minimal residual disease measured by multiparametric flow cytometry prior to allogeneic hematopoietic stem cell transplantation and outcome in children with acute lymphoblastic leukemia

(2010) I. Elorza et al.   HAEMATOLOGICA

Fiber-optic multiphoton flow cytometry in whole blood and in vivo

(2010) Yu-Chung Chang et al.   JOURNAL OF BIOMEDICAL OPTICS

Minimal residual disease-directed therapy for childhood acute myeloid leukaemia: results of the AML02 multicentre trial

(2010) Jeffrey E Rubnitz et al.   LANCET ONCOLOGY

Mass Cytometry: Technique for Real Time Single Cell Multitarget Immunoassay Based on Inductively Coupled Plasma Time-of-Flight Mass Spectrometry

(2009) Dmitry R. Bandura et al.   ANALYTICAL CHEMISTRY

AML with mutated NPM1 carrying a normal or aberrant karyotype show overlapping biologic, pathologic, immunophenotypic, and prognostic features

(2009) C. Haferlach et al.   BLOOD

In vivo, Noninvasive, Label-Free Detection and Eradication of Circulating Metastatic Melanoma Cells Using Two-Color Photoacoustic Flow Cytometry with a Diode Laser

(2009) E. I. Galanzha et al.   CANCER RESEARCH

Role of Minimal Residual Disease Monitoring in Adult and Pediatric Acute Lymphoblastic Leukemia

(2009) Dario Campana   HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA

In vivofiber-based multicolor photoacoustic detection and photothermal purging of metastasis in sentinel lymph nodes targeted by nanoparticles

(2009) Ekaterina I. Galanzha et al.   Journal of Biophotonics

Minimal Disseminated Disease in Childhood T-Cell Lymphoblastic Lymphoma: A Report From the Children's Oncology Group

(2009) Elaine Coustan-Smith et al.   JOURNAL OF CLINICAL ONCOLOGY

Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia

(2009) Elaine Coustan-Smith et al.   LANCET ONCOLOGY

Combination of cladribine and cytarabine is effective for childhood acute myeloid leukemia: results of the St Jude AML97 trial

(2009) J E Rubnitz et al.   LEUKEMIA

In vivo magnetic enrichment and multiplex photoacoustic detection of circulating tumour cells

(2009) Ekaterina I. Galanzha et al.   Nature Nanotechnology

Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group study

(2008) M. J. Borowitz et al.   BLOOD

Allogeneic stem cell transplantation in acute myeloid leukemia: a risk-adapted approach

(2008) Tom Lodewyck et al.   BLOOD REVIEWS

Status of minimal residual disease after induction predicts outcome in both standard and high-risk Ph-negative adult acute lymphoblastic leukaemia. The Polish Adult Leukemia Group ALL 4-2002 MRD Study

(2008) Jerzy Holowiecki et al.   BRITISH JOURNAL OF HAEMATOLOGY